ResearchSafe

Vilon added to the KLOW stack or just wasting my time?

Posted by tiredmegan in Protocols & Stacks - 43 points, 2 comments.

I have been running the KLOW stack /peptides/klow-stack for a few weeks now. For what it is worth, the regeneration feels grand, but I am thinking about adding Vilon /peptides/vilon to the mix to see if the immune regulation side of things actually does anything for my recovery.

The plan is to keep the BPC-157 and KPV daily at 500mcg, and the TB-500 and GHK-Cu a few times a week. I would just throw in the Vilon once a day for a short course.

Is this actually a smart way to optimise the repair or am I just trying to turn myself into a lab rat for the sake of it? I do not want to overdo the immune modulation and end up feeling like a zombie. Does adding a bioregulator to a heavy regenerative stack even make sense or is it just a fancy way to spend more money? Your man in the other thread mentioned short courses for Vilon, so I am wondering if that fits here.

Comments

  • busy_mobility: Adding Vilon to a stack like that seems a bit much for me. Im always a bit cautious about layering too many things that mess with the immune system at once. When I dealt with that calf strain, I stuck to the basics and it felt spot on. I reckon adding more doesnt always mean better repair, and you might just be spending money for nothing. If you really want to try it, a short course makes more sense than long term use. Just keep an eye on how you feel. If you start feeling sluggish or off, its
  • tiredmegan: Fair play for the warning. For what it is worth, I am definitely leaning towards the short course idea since I am terrified of feeling like a zombie. I have not checked my bloods in a few months, so I should probably get that sorted before I go adding more variables. Did you find that sticking to the basics helped with the inflammation specifically, or was it just about the actual tissue repair for your calf?

Community discussion - research and educational context only. Not medical advice.